What Does This Have to Do With Space?
You've all seen this morning's Merck–Moderna announcement.
The melanoma results are about combining Keytruda with a personalized cancer vaccine, training the immune system to recognize the specific mutations in a patient's tumor.
Part of Keytruda's formulation research happened aboard the International Space Station.
Space did not make Keytruda better at killing cancer but it gave scientists something almost impossible to create on Earth, a laboratory where gravity don't interfere with crystal growth.
Microgravity might have helped reveal a better way to handle one of the world’s most important cancer medicines.
$RDW: Here’s the recording for today’s discussion with Peter Cannito, CEO & Chairman of Redwire.
We had some technical difficulties getting started, but Brett came to the rescue and set up his own link.
Thanks for sticking with us, and I hope you enjoy the conversation!
https://t.co/Nk7cTuUROo